Francisco Noya, McGill University

Research

Read how they describe their research on their McGill University profile.

Vaccines clinical trials asthma (pediatric)written action plan clinical practice evaluation

Latest papers

Shashi-Pena syndrome with late-onset specific hypogammaglobinaemia and autoimmune cytopenia.
BMJ case reports · 2025
Factors associated with intention for revaccination among patients with adverse events following immunization
Vaccine · 2023
Life-threatening viral disease in a novel form of autosomal recessive IFNAR2 deficiency in the Arctic.
The Journal of experimental medicine · 2022

All 7 publications

Latest funding

Canadian Immunization Research Network
CIHR · 2017 · Co-investigator
$932,667

All 1 grants and awards

7 publications.

01

Shashi-Pena syndrome with late-onset specific hypogammaglobinaemia and autoimmune cytopenia.

Al Ali A, Saidalani A, Yeganeh M, Russell L, Alizadehfar R, Noya F, McCusker C, Mazer B

BMJ case reports2025

DOI: 10.1136/bcr-2024-263643 PMID: 40759503

02

Factors associated with intention for revaccination among patients with adverse events following immunization

Muñoz CE, Pham-Huy A, Pernica JM, Boucher FD, De Serres G, Vaudry W, Constantinescu C, Sadarangani M, Bettinger JA, Tapiéro B

Vaccine20233 citationsOpen Access

DOI: 10.1016/j.vaccine.2023.08.067

03

Life-threatening viral disease in a novel form of autosomal recessive IFNAR2 deficiency in the Arctic.

Duncan CJA, Skouboe MK, Howarth S, Hollensen AK, Chen R, Børresen ML, Thompson BJ, Stremenova Spegarova J, Hatton CF, Stæger FF, Andersen MK, Whittaker J, Paludan SR, Jørgensen SE, Thomsen MK, Mikkelsen JG, Heilmann C, Buhas D, Øbro NF, Bay JT, Marquart HV, de la Morena MT, Klejka JA, Hirschfeld M, Borgwardt L, Forss I, Masmas T, Poulsen A, Noya F, Rouleau G, Hansen T, Zhou S, Albrechtsen A, Alizadehfar R, Allenspach EJ, Hambleton S, Mogensen TH

The Journal of experimental medicine202292 citationsOpen Access

DOI: 10.1084/jem.20212427 PMID: 35442417

04

Revaccination and Adverse Event Recurrence in Patients with Adverse Events following Immunization

Muñoz CE, MacDonald B, Pham-Huy A, Vaudry W, Pernica JM, Boucher FD, Constantinescu C, Sadarangani M, Bettinger JA, Tapiéro B

Journal of Pediatrics202214 citationsOpen Access

DOI: 10.1016/j.jpeds.2022.07.019

05

A novel pathogenic SH2D1A mutation for X-linked lymphoproliferative syndrome type 1.

Feteih A, Alkhammash S, Zavalkoff S, Mitchell D, Noya F, McCusker C

Clinical immunology (Orlando, Fla.)2020

DOI: 10.1016/j.clim.2020.108569 PMID: 32791311

06

Asthma

Quirt J, Hildebrand KJ, Mazza J, Noya F, Kim H

Allergy, Asthma & Clinical Immunology2018160 citationsOpen Access

DOI: 10.1186/s13223-018-0279-0 PMID: W4238760231

07

CSACI position statement: systemic effect of inhaled corticosteroids on adrenal suppression in the management of pediatric asthma

Issa-El-Khoury K, Kim H, Chan ES, Vander Leek T, Noya F

Allergy, Asthma & Clinical Immunology201536 citationsSenior authorOpen Access

DOI: 10.1186/s13223-015-0075-z PMID: W2135147363

Canadian Immunization Research Network

Co-investigatorCIHR2017Canadian Immunization Research Network - Full application

Principal investigators: Halperin, Scott A; Andrew, Melissa K; Bettinger, Julie A; Bolotin, Shelly; Brisson, Marc; Burchell, Ann N; Coleman, Brenda L; Crowcroft, Natasha S; De Serres, Gaston; De Wals, Philippe; Deeks, Shelley L; Doroshenko, Alexander; Dubé, Eve; Gagneur, Arnaud A; Kwong, Jeffrey C; Langley, Joanne M; Loeb, Mark B; McNeil, Shelly A; Sadarangani, Manish; Top, Karina A; Ulanova, Marina; Ward, Brian J

Keywords: Adverse Events Following Immunization; Immunogenicity; Population-Based Methodology; Rapid Response Research Capacity; Vaccine Coverage; Vaccine Effectiveness; Vaccine Hesitancy; Vaccine Modeling And Economic Analysis; Vaccine Safety; Vulnerable Populations

$932,667

From public funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998 with their latest competition results, the Canada Foundation for Innovation, Genome Canada, the Canadian Space Agency, Canada Research Chairs, the Fonds de recherche du Québec, Ontario research funding, Michael Smith Health Research BC, the Canadian Cancer Society, Heart & Stroke and Brain Canada.

Frequent collaborators

Scott Halperin and Julie Bettinger: 90 shared papers
Julie Bettinger and Manish Sadarangani: 73 shared papers
Manish Sadarangani and Karina Top: 66 shared papers
Scott Halperin and Wendy Vaudry: 60 shared papers
Scott Halperin and Manish Sadarangani: 53 shared papers
Julie Bettinger and Karina Top: 52 shared papers
Shaun Morris and Manish Sadarangani: 46 shared papers
Julie Bettinger and Wendy Vaudry: 45 shared papers
Scott Halperin and Karina Top: 41 shared papers
Shaun Morris and Karina Top: 34 shared papers
Guy Rouleau and Sirui Zhou: 26 shared papers
Scott Halperin and Shaun Morris: 24 shared papers
Jeffrey (Des) Pernica and Manish Sadarangani: 20 shared papers
Karina Top and Wendy Vaudry: 20 shared papers
Jeffrey (Des) Pernica and Karina Top: 17 shared papers
Cora-Mihaela Constantinescu and Karina Top: 16 shared papers
Jeffrey (Des) Pernica and Scott Halperin: 14 shared papers
Manish Sadarangani and Juthaporn Cowan: 13 shared papers
Manish Sadarangani and Cora-Mihaela Constantinescu: 11 shared papers
Juthaporn Cowan and Karina Top: 11 shared papers
Scott Halperin and Cora-Mihaela Constantinescu: 8 shared papers
Jeffrey (Des) Pernica and Juthaporn Cowan: 6 shared papers
Jaclyn Quirt and Harold Kim: 5 shared papers
Bruce Mazer and Julia Upton: 5 shared papers
Karina Top and Julia Upton: 4 shared papers
Harold Kim and Bruce Mazer: 3 shared papers
Jeffrey (Des) Pernica and Zainab Abdurrahman: 3 shared papers
Zainab Abdurrahman and Manish Sadarangani: 3 shared papers
Zainab Abdurrahman and Juthaporn Cowan: 3 shared papers
Manish Sadarangani and Julia Upton: 3 shared papers
Jaclyn Quirt and Bruce Mazer: 2 shared papers
Harold Kim and Juthaporn Cowan: 2 shared papers
Harold Kim and Francisco Noya: 2 shared papers
Jeffrey (Des) Pernica and Francisco Noya: 2 shared papers
Scott Halperin and Francisco Noya: 2 shared papers
Julie Bettinger and Francisco Noya: 2 shared papers
Shaun Morris and Francisco Noya: 2 shared papers
Manish Sadarangani and Francisco Noya: 2 shared papers
Cora-Mihaela Constantinescu and Francisco Noya: 2 shared papers
Francisco Noya and Karina Top: 2 shared papers
Francisco Noya and Wendy Vaudry: 2 shared papers
Jaclyn Quirt and Francisco Noya: 1 shared paper
Zainab Abdurrahman and Francisco Noya: 1 shared paper
Bruce Mazer and Laura Russell: 1 shared paper
Bruce Mazer and Francisco Noya: 1 shared paper
Guy Rouleau and Daniela Buhas: 1 shared paper
Guy Rouleau and Laura Russell: 1 shared paper
Guy Rouleau and Francisco Noya: 1 shared paper
Sirui Zhou and Daniela Buhas: 1 shared paper
Sirui Zhou and Francisco Noya: 1 shared paper
Juthaporn Cowan and Francisco Noya: 1 shared paper
Daniela Buhas and Francisco Noya: 1 shared paper
Laura Russell and Francisco Noya: 1 shared paper
Francisco Noya and Julia Upton: 1 shared paper

Department of Pediatrics
Department of Medicine
Department of Human Genetics
Pediatrics Dept
Cumming School of Medicine
Epidemiology Division
Department of Neurology and Neurosurgery
Other

Applying for

Paper to mention

Subject: Prospective PhD student: Vaccines Dear Professor Noya, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Shashi-Pena syndrome with late-onset specific hypogammaglobinaemia and autoimmune cytopenia." (2025), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]